Autolus Therapeutics plc revenue breakdown overview

Autolus Therapeutics plc revenue for the last year amounted to 1.70 M USD, the most of which — 1.70 M USD — came from its highest performing source at the moment, Chimeric Antigen Receptors T Cell Therapies, the year earlier bringing 6.36 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Autolus Therapeutics plc 1.35 M USD.